Full Press Release Details
Initial Director s Interest
Initial Director s Interest Notice
Information or documents not available now must be
given to ASX as soon as available. Information and documents given to ASX become ASX s property and may be made public.
Introduced 30/9/2001.
PRIMA BIOMED LTD (ASX:PRR)
We (the entity) give ASX the following information under listing rule
3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
Part 1 - Director s relevant interests in securities of which the director
is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a director should be disclosed in this part.
Number & class of securities
720,000 ordinary fully paid shares
78,125 options exercisable at $0.20 each and expiring on 19th June 2017
450,000 unlisted options exercisable at $0.185 and expiring on 1st August 2015
643,629 unlisted options exercisable at $0.0774 and expiring on 30th June 2018
150 American Depositary Receipts (ADRs). The ADRs are traded on NASDAQ
= 30 ordinary fully paid shares
+ See chapter 19 for defined terms.
Initial Director s Interest
Part 2 Director s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest
Number & class of Securities
Note: Provide details of the circumstances giving rise to the relevant interest.
Part 3 Director s interests in contracts
Note: In the case of a
company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be disclosed in this part.
Name of registered holder
(if issued securities)
No. and class of securities to which interest relates
+ See chapter 19 for defined terms.